Spyre Therapeutics, Inc. · NASDAQ:SYRE

Perceptive Advisors LLC reported a 5.00% stake in Spyre Therapeutics, Inc. (Schedule 13G)

Event Apr 15, 2026 · Filed Apr 22, 2026

Perceptive Advisors LLC reported a 5.00% stake in Spyre Therapeutics, Inc., 4,319,496 shares, as a passive investor on Apr 15, 2026. Filed Apr 22, 2026 (Schedule 13G).

Stake
5.00%
Shares
4,319,496
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Perceptive Advisors LLC5.00%4,319,496
Joseph Edelman5.00%4,319,496
Perceptive Life Sciences Master Fund, Ltd.5.00%4,319,496

Source

View original at SEC

Related